Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of Patients with Hematologic Malignancies Using Busulfan, Fludarabine, and Total Body Irradiation Conditioning Is Effective in an Elderly and Infirm Population

Jonathan E. Brammer(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Richard T. Maziarz(Oregon Health & Science University), Brandon Hayes‐Lattin(Oregon Health & Science University), Eneida R. Nemecek(Oregon Health & Science University), N. Subbiah(Oregon Health & Science University), Gabrielle Meyers(Oregon Health & Science University), Peter Curtin(City Of Hope National Medical Center), Alexander Stentz(Oregon Health & Science University), Gundula Palmbach(Oregon Health & Science University), G. Perets Avraham(Oregon Health & Science University), Tibor Kovacsovics(Hôpital Edouard Herriot), Susan Slater(Oregon Health & Science University), Rachel Frires(Oregon Health & Science University), José F. Leis(Mayo Clinic), James Gajewski(The University of Texas MD Anderson Cancer Center)
Transplantation and Cellular Therapy
October 16, 2014
10.1016/j.bbmt.2014.09.024
Cited by 11

Related Papers

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
|Blood|1997|1.2k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
|Journal of Clinical Oncology|1998|927
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
|New England Journal of Medicine|1993|848